Cognitive impairment associated with chemotherapy for cancer: report of a workshop - Wikidata - awgldk - TriplyDB

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

http://www.wikidata.org/entity/Q28264071

about

American Cancer Society Colorectal Cancer Survivorship Care Guidelines Cancer- and cancer treatment-associated cognitive change: an update on the state of the science Optimal management of breast cancer in the elderly patient: current perspectives Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction.Cognitive function and breast cancer: promise and potential insights from functional brain imaging.Late effects of blood and marrow transplantation.Memory and cancer: a review of the literature What do perceived cognitive problems reflect?Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer.Characterization and reversal of Doxorubicin-mediated biphasic activation of ERK and persistent excitability in sensory neurons of Aplysia californica.Driving-Related Cognitive Performance in Older Adults with Pharmacologically Treated Cardiovascular Disease.Attitudes toward information about genetic risk for cognitive impairment after cancer chemotherapy: breast cancer survivors compared with healthy controls.Cognitive Effects of Systemic Therapy in Patients with Breast Cancer Breast cancer morbidity: questionnaire survey of patients on the long term effects of disease and adjuvant therapy Manganese superoxide dismutase: beyond life and death Self-reported cognitive concerns and abilities: two sides of one coin?Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development.Symptom management of affective and cognitive disturbance with a group of cancer survivors Homing and restorative effects of bone marrow-derived mesenchymal stem cells on cisplatin injured ovaries in rats Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer.Memory loss during lenalidomide treatment: a report on two cases Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner via an immuno-modulatory circuit.Caregiver-reported neuropsychiatric symptoms in patients undergoing treatment for head and neck cancer: a pilot study Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years A Brief Patient Self-Report Screening Measure of Cancer Treatment-Related Memory Problems: Latent Structure and Reliability Analysis Cognitive function in breast cancer patients prior to adjuvant treatment Health-related quality of life and cancer clinical trials.Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study Psychological intervention for improving cognitive function in cancer survivors: a literature review and randomized controlled trial.Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats A cross-cultural perspective on challenges facing comparative cancer survivorship research.Management of Cancer-related Cognitive Dysfunction-Conceptualization Challenges and Implications for Clinical Research and Practice.Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatment Manganese superoxide dismutase: guardian of the powerhouse.Cognitive impairment after chemotherapy related to atypical network architecture for executive control.Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional study Self-reported memory problems in adult-onset cancer survivors: effects of cardiovascular disease and insomnia

P2860

Q26782671-9ADBBE86-71B6-4492-944A-D8E599BEDD95 Q26853289-59BA98BF-5471-40A4-9118-DB9289131235 Q27690879-F64848A4-2449-4162-9B11-59F0A4BEF6F3 Q30361724-6B489D02-B768-4C75-9F44-32B611F2DD54 Q30390049-9AF8FF9F-2265-40CD-944D-35E121B73240 Q30572890-26EA12E8-EF64-494D-8119-F99DB4E02948 Q33574136-92F14360-4F9E-4809-8BB8-BF02FEF14885 Q33663544-8DA8BE3A-AF6E-4C48-9E9F-E6D70B05AB6A Q33707551-D8CD65AD-1D2F-45D9-8A7F-9EF67E655CA2 Q33816589-D165D175-B2AF-46ED-A3DC-1AF87DA98518 Q33866915-A0376064-0A57-447D-A0E3-5AFD943CDE7F Q33902218-2B40B6DE-7542-43AA-B2E4-53249E7D2783 Q34048798-A9EF7443-1A38-410A-BC5B-B83DEC50ED67 Q34095832-BA89BF4D-DA2D-4F57-B251-8351119456DC Q34106649-D8016583-8CE8-440F-B3ED-9A82AC40438B Q34284548-424C8188-235A-4E2B-A036-DBE835FADE94 Q34288191-D571EFDC-0EF8-49BE-B4D1-2AFA6266E19A Q34587999-66F9BDE4-9C5D-415B-A472-2E1A026E1EFE Q34633028-6F443274-F0E7-409C-8DED-A3786DC4406D Q34674401-C8E069FB-B64A-4870-9413-FA70E70B1E6B Q34768078-A07FAE29-2EFA-4F45-8836-E0BBB124DA98 Q34815323-69152558-CFBE-44F1-8CEE-321DE94D04C0 Q34929303-9A81769D-C119-4164-8913-A51D53369ABE Q34992781-8829F892-9E76-4CD0-BA68-B2C372F6559E Q35006844-80DE9A0F-1DA4-49F5-B714-23E4F8B23041 Q35023468-40DC8F56-097A-463E-B31E-31DD1B4421EA Q35037127-9445ACD7-7159-4717-9D22-D2A3F8D3E9BD Q35043593-C9047D92-88F5-4881-BED7-754BE6CFB548 Q35076356-FCB9943C-735C-4AA2-A371-0AA5C57F04EB Q35120883-38650A24-110C-4D13-95C0-0A01ABA45DC9 Q35128805-F28089CB-5223-4C15-8262-7EC5EBF72FC6 Q35215913-C83F7628-B18C-40E5-87AA-F3EB961B2FB5 Q35243657-9FCFD2A7-1D69-419C-A691-8171B7F3AF87 Q35418565-D1A5A245-EAF7-46C4-B9A2-C639E6E658BA Q35427635-F4476DB3-C874-4D98-9053-6EB09C9785F3 Q35535907-8564A553-A3EB-4117-86D9-375A4FAE646A Q35536092-F46B6AD2-0B8D-44DF-8376-3AFF0ABF4672 Q35667533-2C50DC66-DD0A-4F97-8025-D682D54E396B Q35695833-DEBF3522-0873-4089-9D03-C0910983C3B9 Q35738596-766F8C78-0F57-48B5-A85D-46F4BC5971A9

P2860

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

http://www.wikidata.org/entity/Q28264071

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

name

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

@ast

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

@en

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

@nl

type

label

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

@ast

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

@en

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

@nl

prefLabel

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

@ast

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

@en

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

@nl

P1433

Q28264071-5F0EB05F-2D86-4F0B-A60A-D42C5FAB1CD1

P1476

Q28264071-15CBB5EF-0020-4317-8B7D-B6D9B61145EE

P2093

Q28264071-7E6D5919-382D-4C80-A91B-994DE5CD3DA7

Q28264071-AEAF9385-E8C4-49D7-BFFE-EC997B4744A4

Q28264071-BF9D1A32-43CD-45DC-9CDB-1AD98D20D1A0

Q28264071-D1BC4606-E246-409F-8C8E-3E707648C7D2

P304

Q28264071-40253905-47C9-4B9A-B3A0-03D13FDC409F

P31

Q28264071-F5D48CE2-8C46-40D9-8C2C-5F986BD606DC

P3181

Q28264071-D3F31EAD-BCE5-41EA-9508-5B75A370E68D

P356

Q28264071-E1DD87D0-9B10-405A-8072-013F96C2B18E

P407

Q28264071-34307286-0626-464A-96D4-F097A634A397

P433

Q28264071-361D82F5-EED8-4D50-A15D-439637C24A99

P478

Q28264071-19BBF802-AF7B-4CEB-A559-6EAB7978A412

P577

Q28264071-A780FE4F-AEE8-409E-9271-7FA7364041FC

P5875

Q28264071-26CF8857-E2C0-41D3-BF02-9D8CBF9ADC29

P698

Q28264071-9DBC480D-9C89-4A18-AF68-C0F283A15454

P921

Q28264071-377DA45F-7DFE-4107-B752-EAC427A4F597

Q28264071-DA80AD45-8650-4CFA-BBDD-F786A9B1B028

P3181

P356

JCO.2004.08.094

P1433

Journal of Clinical Oncology

P1476

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

@en

P2093

Frits S Van Dam

http://www.w3.org/2001/XMLSchema#string

Ian F Tannock

http://www.w3.org/2001/XMLSchema#string

Patricia A Ganz

http://www.w3.org/2001/XMLSchema#string

Tim A Ahles

http://www.w3.org/2001/XMLSchema#string

P304

2233-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1721342

http://www.w3.org/2001/XMLSchema#string

P356

10.1200/JCO.2004.08.094

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8536522

http://www.w3.org/2001/XMLSchema#string

P698

15169812

http://www.w3.org/2001/XMLSchema#string

P921